This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study design
Randomized controlled trial. The trial was conducted over seven sites and the average length of follow-up was 5.5 years. No loss to follow up was reported among the surviving populations but the results indicated that 14% of the angioplasty group and 11% of the bypass surgery group died during the trial.
Analysis of effectiveness
The trial was based on intention to treat. The effectiveness of the two treatments was measured in terms of functional status, quality of life, life-years gained and employment status. Instruments used to determine effectiveness were: The Duke Activity Status Index, which provided a functional status score and the RAND Mental Health Inventory, which assesses anxiety, depression and positive affect. Questionnaires were also used to determine employment status every three months throughout the trial.
Effectiveness results
The angioplasty group had a higher mortality rate ((P=0.54), significantly more second or subsequent revascularizations (P<0.001), and significantly more angina after one year (P=0.001) and three years (P=0.01) of follow-up. Functional status of all patients increased by 5.7 units (P<0.001) after one year. The functional status of patients in the bypass group was significantly greater than angioplasty after one year (7.0 vs 4.4 units, P=0.02), two years (5.5 vs 3 units, P=0.02), and 3 years (5.6 vs 3.2 units, P=0.04) of follow-up, but the difference was not significant after four (4.3 vs 2.6 units, P=0.17) or five (3.6 vs 2.0 units, P=0.26) years. Emotional health improved by a mean of 1.8 units (P<0.001) after one year and there was no statistical difference between the groups throughout the follow-up. The proportion of patientswho initially worked and continued to work either full or part time declined to 83% after six months, to 73% after one year, to 57% after 3 years, and to 45% after 5 years, with no statistical difference between the groups. The patients in the angioplasty group returned to work significantly earlier than those in the bypass group (median = 6 vs 11 weeks, P<0.001). After returning to work the hours spent on the job did not differ significantly between the groups.
Clinical conclusions
In patients with multivessel coronary disease, bypass surgery was associated with better functional status for the first three years than coronary angioplasty, after the initial morbidity caused by the procedure has subsided. In other aspects the quality of life was equivalent for both methods.
Measure of benefits used in the economic analysis
The measure of benefit used in the economic analysis was life-years gained.
Direct costs
Direct costs included the initial medical costs of revascularization by either bypass surgery of angioplasty, plushospitalization and medication costs incurred over the period of follow-up. Costs were discounted at 3%. Prices were determined by each hospital's Medicare cost report. When data on charges were unavailable the 1995 Medicare reimbursement for the diagnosis-related group (DRG) specific to the patient's diagnosis was used. Physicians' charges were obtained from the participating hospitals, and Medicare rates of reimbursement to physicians were assigned to office visits. Costs for cardiac medications were calculated on the basis of the average wholesale prices in the 1995 Red Book. Costs were calculated over the period of follow-up of approximately five years and converted to 1995 prices.
Statistical analysis of costs
Statistical analyses of costs were conducted using the Wilcoxon rank-sum test. The time course of the accumulation of costs during the follow-up period was described using the life-table method. Variability in cost was assessed by means of a permutation test and base-line predictors of costs were assessed by linear regression, with the logarithm of the
